CV Sciences Q4 CBD Revenue Drops 34% from a Year Ago

CV Sciences, Inc. Reports Fiscal Year-End 2019 Financial Results Record full year revenue SAN DIEGO, March 16, 2020 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”,...
- March 16th, 2020 at 4:43 pm

Another Black Swan Event for the Cannabis Industry

You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
- March 15th, 2020 at 10:58 am

Tilray Prices $90.4 Million Equity Offering at $4.76

Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering NANAIMO, British Columbia, March 13, 2020–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis...
- March 13th, 2020 at 9:24 am

Vireo Health Raises C$10.5 Million Selling Stock and Warrants

Vireo Health Raises $10.5 Million to Increase Sales Volume and Margin CAD $10.5 million financing to increase retail sell through in key medical only markets Management provides update regarding recent strategic...
- March 10th, 2020 at 7:25 am

Rightsizing the Cannabis Industry

You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
- March 8th, 2020 at 10:56 am